Arvinas makes two new internal appointments

Arvinas reports that two members of the senior leadership team were appointed to expanded roles at the company. Andy Crew, Ph.D., has been appointed Chief Technology Officer, and Ian Taylor, Ph.D., has been appointed Chief Scientific Officer.

“Combined, these appointments within our management team will be critical as we advance our lead oncology programs, ARV-110 and ARV-471, and continue ramping up work on new programs,” said John Houston, Ph.D., President and CEO of Arvinas.